Key Drivers
- High gross margin
- Weak net returns
- Elevated intangibles
AIAI Summary
EverCommerce's pivot from acquisitive growth to a capital‑disciplined, margin- and cash-focused operator means the investment now hinges on execution—specifically stabilized payments/TPV monetization and clear AI product monetization (EverHealth Scribe/ZyraTalk) to validate FY26 adjusted EBITDA and levered cash-flow targets, otherwise the rich valuation leaves little downside protection against payments weakness, legal liabilities, or missed margin realization.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Weak net returns
- •Elevated intangibles
EVCM combines strong revenue scale, very high gross margins and solid operating cash flow with adequate short-term liquidity, but weak net profitability, heavy intangibles, negative retained earnings and meaningful leverage leave valuation stretched.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Support near $10
- •Event-driven risk
Trading below its last-month SMA with an RSI ~41, the stock has firm support near $10.00 but must clear the low-$12s to regain upside and remains exposed to event-driven downside.
Sharp intraperiod drop on 2026-03-13 indicating event-driven volatility and downside tail risk
Sentiment & News
Key News Insights:
- •Modest revenue growth
- •EPS miss/stock gap
- •Renewed litigation risk
EverCommerce reported modest 5.2% revenue growth but missed EPS expectations, prompting a sharp post-earnings stock gap amid renewed investor litigation despite product progress with DrChrono's EverHealth Scribe.
The EPS shortfall and legal scrutiny will likely keep near-term downside pressure on the stock despite product wins that could support a gradual recovery
Similar Companies in Technology
Other companies in the same sector with AI ratings